Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Cornova
AddedFeb 15, 2024
UpdatedJun 18, 2026
Cornova

Cornova

Acquired

CorNova, Inc.: Global developer of coronary and peripheral endovascular products, including stents and catheters.

HQ
Burlington, MA, US
Founded
2003
Overview
Compare
Fundraising
Employees

CorNova, Inc. is a global developer of coronary and peripheral endovascular products. The company designs and produces stent deployment and delivery systems, post-dilatation catheters, and bare-metal stents for arterial injuries and coronary stent systems. CorNova aims to innovate in the medical device industry, focusing on improving patient outcomes through advanced endovascular solutions.

CorNova has made significant strides in the medical device sector, impacting patient care worldwide with its innovative products. The company's stent and catheter technologies have been adopted globally, enhancing the treatment of coronary and peripheral artery diseases.

Cornova - Similar Companies

Novostent logo

Novostent

Concept Medical logo

Concept Medical

conceptmedical.com

Corinnova logo

Corinnova

corinnova.com

Viacor logo

Viacor

Medlogics Device logo

Medlogics Device

Trireme Medical logo

Trireme Medical

Traverse Vascular logo

Traverse Vascular

Cordis logo

Cordis

cordis.com

Svelte Medical Systems logo

Svelte Medical Systems

Neurvana Medical logo

Neurvana Medical

Penumbra logo

Penumbra

penumbrainc.com

Ostial logo

Ostial

ostialcorp.com

Cross Vascular logo

Cross Vascular

eLum Technologies logo

eLum Technologies

Venarum Medical logo

Venarum Medical

Cornova - Quick Facts

Who are Cornova's competitors?

Companies similar to Cornova include Novostent, Concept Medical, Corinnova and Viacor.

When was Cornova founded?

Cornova was founded in 2003.

Where is Cornova's headquarters located?

Cornova's headquarters is located in Burlington, MA, US.

When was Cornova's last funding round?

Cornova's most recent funding round was for $385k (USD) in January 2011.

How much has Cornova raised to-date?

As of Jan 7, 2011, Cornova has raised a total of $10.9M (USD).

Cornova - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Transactional
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthcare
  • Healthtech
  • Medical
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 8 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research